Log in

JSE:APN - Aspen Pharmacare Stock Price, Forecast & News

Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume2.87 million shs
Average Volume1.87 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Aspen Pharmacare Holdings Limited is a South Africa-based supplier and manufacturer of branded and generic pharmaceutical products, as well as infant nutritional and consumer healthcare products. The Company's segments include International, South Africa, Asia Pacific and Sub-Saharan Africa (SSA). Its International business includes operating subsidiaries in Europe, Commonwealth of Independent States (CIS), Latin America, the Middle East and North Africa, Canada, as well as Mauritius-based Aspen Global Incorporated. The South African business provides branded, generic, over-the-counter, consumer health and infant nutritional products, which are supplied to pharmacies, retail pharmacy chains, hospitals, clinics, prescribing specialists, dispensing general practitioners, managed healthcare funders and retail stores across the private and public sectors in South Africa. Its business in Asia Pacific includes operations in Australasia, the Philippines, Taiwan and Japan.
Read More

Industry, Sector and Symbol

Industry N/A



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable

Receive APN News and Ratings via Email

Sign-up to receive the latest news and ratings for APN and its competitors with MarketBeat's FREE daily newsletter.

Aspen Pharmacare (JSE:APN) Frequently Asked Questions

Has Aspen Pharmacare been receiving favorable news coverage?

Media stories about APN stock have trended very negative this week, InfoTrie reports. InfoTrie ranks the sentiment of news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Aspen Pharmacare earned a coverage optimism score of -3.0 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 4.0 out of 10, meaning that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the immediate future. View the latest news aboutAspen Pharmacare.

What other stocks do shareholders of Aspen Pharmacare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aspen Pharmacare investors own include Steinhoff International (SNH), Boeing (BA), Altaba (AABA), Provident Financial (PFG), MC Mining (MCM), AstraZeneca (AZN) and Wirecard (WDI).

Who are Aspen Pharmacare's key executives?

Aspen Pharmacare's management team includes the following people:
  • Stephen Bradley Saad, Group Chief Executive, Executive Director (Age 53)
  • Michael Guy Attridge, Deputy Group Chief Executive, Executive Director (Age 56)
  • Riaan Verster, Company Secretary & Group Governance Officer (Age 41)
  • Kuseni Douglas Dlamini, Non-Executive Chairman of the Board (Age 49)
  • Roy Cecil Andersen CPA, Lead Independent Non-Executive Director (Age 69)
  • Christopher Nattle Mortimer, Non-Executive Director (Age 56)
  • David Redfern, Non-Executive Director (Age 51)
  • John Frederick Buchanan, Non-Executive Independent Director (Age 72)

What is Aspen Pharmacare's stock symbol?

Aspen Pharmacare trades on the JSE under the ticker symbol "APN."

How do I buy shares of Aspen Pharmacare?

Shares of APN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Aspen Pharmacare's official website?

The official website for Aspen Pharmacare is http://www.aspenpharma.com/.

How can I contact Aspen Pharmacare?

Aspen Pharmacare's mailing address is Woodmead, JOHANNESBURG, 2194, South Africa. The company can be reached via phone at +27-11-2396100.

MarketBeat Community Rating for Aspen Pharmacare (JSE APN)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  44 (Vote Outperform)
Underperform Votes:  51 (Vote Underperform)
Total Votes:  95
MarketBeat's community ratings are surveys of what our community members think about Aspen Pharmacare and other stocks. Vote "Outperform" if you believe APN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe APN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 4/1/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel